 |
|
Home | Insider Selling: BioMarin Pharmaceutical CEO Sells 3,000 Shares of Stock (BMRN) |
 |
Insider Selling: BioMarin Pharmaceutical CEO Sells 3,000 Shares of Stock (BMRN)
|
 |
- October 15, 2013
-
BioMarin Pharmaceutical (NASDAQ:BMRN) CEO Jean Jacques Bienaime sold 3,000 shares of the stock in a transaction dated Thursday, October 10th. The stock was sold at an average price of $66.76, for a total value of $200,280.00. The sale was disclosed in a document filed with the SEC, which is available at this link. BMRN has […]This article (Insider Selling: BioMarin Pharmaceutical CEO Sells 3,000 Shares of Stock (BMRN)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2013/10/15/insider-selling-biomarin-pharmaceutical-ceo-sells-3000-shares-of-stock-bmrn/
|
 |
|
 |
|
 |
